Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 26;23(5):124.
doi: 10.1208/s12249-022-02280-2.

Drotaverine Hydrochloride Superporous Hydrogel Hybrid System: a Gastroretentive Approach for Sustained Drug Delivery and Enhanced Viscoelasticity

Michael M Farag  1 , Mina M Louis  2 , Alia A Badawy  3 , Demiana I Nessem  2 , Nevine S Abd Elmalak  3   4
Affiliations

Drotaverine Hydrochloride Superporous Hydrogel Hybrid System: a Gastroretentive Approach for Sustained Drug Delivery and Enhanced Viscoelasticity

Michael M Farag et al. AAPS PharmSciTech. .

Abstract

This study aims to prepare drotaverine hydrochloride superporous hydrogel hybrid systems (DSHH systems) to prolong its residence time in the stomach, provide extended release and reduce its frequency of administration. Drotaverine hydrochloride (DRH) is a spasmolytic drug that suffers from brief residence due to intestinal hypermotility during diarrheal episodes associated with gastrointestinal colics resulting in low bioavailability and repeated dosing. Eight DSHH systems were prepared using gas blowing technique. The prepared DSHH systems were evaluated regarding their morphology, incorporation efficiency, density, porosity, swelling ratio, viscoelastic property, erosion percentage and release kinetics. The FH8 formula containing equal proportion of chitosan (3%) /polyvinyl alcohol (3%) as strengthener and crosslinked with tripolyphosphate showed the highest incorporation efficiency (91.83 ± 1.33%), good swelling ratio (28.32 ± 3.15% after 24 h), optimum viscoelastic properties (60.19 ± 3.82 kPa) and sustained release profile (88.03 ± 2.15% after 24 h). A bioequivalence study was done to compare the bioavailability of the candidate formula versus Spasmocure®. Statistical analysis showed significant (P < 0.05) increase in bioavailability 2.7 folds with doubled Tmax (4 h) compared to the marketed product (2 h). These results declared that the superporous hydrogel hybrid systems could be a potential gastroretentive approach for the sustained delivery of drugs with short residence time with enhanced viscoelasticity.

Keywords: drotaverine hydrochloride; gastroretentive; hydrogel; superporous; sustained drug delivery.

PubMed Disclaimer

References

    1. Kumar D, Kumar A, Malik JK. Preformulation studies of drotaverine hydrochloride: an integral part of formulation design. European Journal of Biomedical and Pharmaceutical Sciences. 2019;6(13):304–7.
    1. Mehmood Y, Mahmood RK, Akram W. Development and validation of UV-spectrophotometric methods for quantitative estimation of drotaverine HCl injection. Pharm Methods. 2017;8(1):31–5.
    1. Patel P, Dand N, Somwanshi A, Kadam VJ, Hirlekar RS. Design and evaluation of a sustained release gastroretentive dosage form of captopril: a technical note. AAPS PharmSciTech. 2008;9(3):836–9. - PubMed - PMC
    1. Kushal M, Monali M, Durgavati M, Mittal P, Umesh S, Pragna S. Oral controlled release drug delivery system: an overview. Int Res J Pharm. 2013;4(3):70–6.
    1. Kumar S, Jamil F, Rajput M, Sharma S. Gastro Retentive Drug Delivery System : Features and Facts. Int J Res Pharm Biomed Sci. 2012;3(1):125–36.

MeSH terms

LinkOut - more resources